Uppsala, Sweden

Agneta Siegbahn


Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2002-2010

Loading Chart...
2 patents (USPTO):

Title: Agneta Siegbahn: Innovator in Gene Expression and Cell Migration

Introduction

Agneta Siegbahn is a prominent inventor based in Uppsala, Sweden. She has made significant contributions to the field of gene expression and cell migration, holding a total of 2 patents. Her work focuses on therapeutic treatments that can regulate cell behavior, which is crucial in various medical applications.

Latest Patents

Agneta Siegbahn's latest patents include innovative methods for utilizing factor VIIa and tissue factor antagonists. One of her patents describes the use of factor VIIa or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis. This invention relates to therapeutic treatments for pathological conditions associated with cell migration. Another patent outlines methods for modifying cell motility using factor VIIa or inactivated factor VIIa, which involves contacting tissue factor-expressing cells with an effective amount of Factor VIIa agonist.

Career Highlights

Throughout her career, Agneta has worked with notable companies such as Novo Nordisk A/S and Novo Nordisk Healthcare AG. Her experience in these organizations has allowed her to develop and refine her innovative ideas in the field of biotechnology.

Collaborations

Agneta has collaborated with esteemed colleagues, including Lars Christian Petersen and Mirella Ezban. Their combined expertise has contributed to advancements in their respective fields.

Conclusion

Agneta Siegbahn's work in gene expression and cell migration showcases her innovative spirit and dedication to improving therapeutic treatments. Her patents reflect her commitment to advancing medical science and enhancing patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…